LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

Search

Aurinia Pharmaceuticals Inc

Cerrado

SectorSalud

8.07 1.13

Resumen

Variación precio

24h

Actual

Mínimo

7.89

Máximo

8.13

Métricas clave

By Trading Economics

Ingresos

22M

23M

Ventas

2.6M

62M

P/B

Media del Sector

29.482

51.198

BPA

0.16

Margen de beneficio

37.371

Empleados

130

EBITDA

15M

22M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+22.03% upside

Dividendos

By Dow Jones

Próximas Ganancias

31 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-53M

1.1B

Apertura anterior

6.94

Cierre anterior

8.07

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

167 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Aurinia Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 jun 2025, 20:45 UTC

Ganancias

Broadcom 2Q Sales Climb on Booming AI Demand

5 jun 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 jun 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 jun 2025, 23:30 UTC

Charlas de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 jun 2025, 21:32 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 20:45 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:24 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Rev $15B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Net $4.97B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Adj EPS $1.58 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom Sees 3Q Rev $15.8B >AVGO

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 jun 2025, 19:22 UTC

Charlas de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 jun 2025, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 jun 2025, 18:32 UTC

Charlas de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 jun 2025, 18:26 UTC

Ganancias

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 jun 2025, 18:06 UTC

Charlas de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 jun 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 jun 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 16:18 UTC

Charlas de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 jun 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 jun 2025, 16:03 UTC

Charlas de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 jun 2025, 15:49 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Aurinia Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

22.03% repunte

Estimación a 12 meses

Media 9.75 USD  22.03%

Máximo 11 USD

Mínimo 8 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

8.1 / 8.21Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

167 / 380 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.